VIENNA, Dec 4 (Reuters) – Novartis Chief Executive
Joe Jimenez has played down suggestions the Swiss drugmaker
could bid for Swiss biotech group Actelion, which is in
talks with U.S. healthcare group…
The post Novartis CEO plays down prospects for Actelion bid – Blick appeared first on NASDAQ.